Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ALBO - Albireo Pharma Inc. (ALBO) CEO Ron Cooper on Q4 2020 Results - Earnings Call Transcript

ALBO - Albireo Pharma Inc. (ALBO) CEO Ron Cooper on Q4 2020 Results - Earnings Call Transcript

Albireo Pharma Inc.
Albireo Pharma, Inc. (ALBO) Q4 2020 Earnings Conference Call February 25, 2021 10:00 AM ET Company Participants Paul Arndt - Managing Director-LifeSci Advisors Ron Cooper - President & Chief Executive Officer Simon Harford - Chief Financial Officer Pat Horn - Chief Medical Officer Pamela Stephenson - Chief Commercial Officer Conference Call Participants Yasmeen Rahimi - Piper Sandler Liana Moussatos - Wedbush Securities Brian Skorney - Baird Joseph Stringer - Needham & Company Tim Lugo - William Blair Ed Arce - H.C. Wainwright Presentation Operator Good morning, and welcome to the Albireo Pharma's Fourth Quarter and Year End 2020 Financial Results and Business Update Presentation. At this time, all participants are in a listen-only mode. A Q&A session will follow the formal presentation. [Operator Instructions] Please note that this conference is being recorded. I'll now turn the call over to your host, Paul Arndt, Managing Director of LifeSci Advisors. Thank you.

For further details see:

Albireo Pharma, Inc. (ALBO) CEO Ron Cooper on Q4 2020 Results - Earnings Call Transcript
Stock Information
Company Name: Albireo Pharma Inc.
Stock Symbol: ALBO
Market: NASDAQ
Menu
ALBO ALBO Quote ALBO Short ALBO News ALBO Articles ALBO Message Board
Get ALBO Alerts

News, Short Squeeze, Breakout and More Instantly...